Literature DB >> 22202053

The potential origin of glioblastoma initiating cells.

David A Chesler1, Mitchell S Berger, Alfredo Quinones-Hinojosa.   

Abstract

Despite intensive clinical and laboratory research and effort, Glioblastoma remains the most common and invariably lethal primary cancer of the central nervous system. The identification of stem cell and lineage-restricted progenitor cell populations within the adult human brain in conjunction with the discovery of stem-like cells derived from gliomas which are themselves tumorigenic and have been shown to have properties of self-renewal and multipotency, has led to the hypothesis that this population of cells may represent glioma initiating cells. Extensive research characterizing the anatomic distribution and phenotype of neural stem cells in the adult brain, and the genetic underpinnings needed for malignant transformation may ultimately lead to the identification of the cellular origin for glioblastoma. Defining the cellular origin of this lethal disease may ultimately provide new therapeutic targets and modalities finally altering an otherwise bleak outcome for patients with glioblastoma.

Entities:  

Mesh:

Year:  2012        PMID: 22202053      PMCID: PMC3635065          DOI: 10.2741/S261

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  160 in total

1.  Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein.

Authors:  J G Gleeson; K M Allen; J W Fox; E D Lamperti; S Berkovic; I Scheffer; E C Cooper; W B Dobyns; S R Minnerath; M E Ross; C A Walsh
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

2.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

3.  Doublecortin is preferentially expressed in invasive human brain tumors.

Authors:  Marie-Claire Daou; Thomas W Smith; N Scott Litofsky; Chung C Hsieh; Alonzo H Ross
Journal:  Acta Neuropathol       Date:  2005-09-30       Impact factor: 17.088

4.  Developing forebrain astrocytes are sensitive to thyroid hormone.

Authors:  E Gould; M Frankfurt; A Westlind-Danielsson; B S McEwen
Journal:  Glia       Date:  1990       Impact factor: 7.452

5.  Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.

Authors:  Tatyana N Ignatova; Valery G Kukekov; Eric D Laywell; Oleg N Suslov; Frank D Vrionis; Dennis A Steindler
Journal:  Glia       Date:  2002-09       Impact factor: 7.452

6.  The development of experimental brain tumours a sequential light and electron microscope study of the subependymal plate. II. Microtumours.

Authors:  G J Pilkington; P L Lantos
Journal:  Acta Neuropathol       Date:  1979-03-15       Impact factor: 17.088

7.  N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma.

Authors:  Samuel R Browd; Anna M Kenney; Oren N Gottfried; Joon Won Yoon; David Walterhouse; Carolyn A Pedone; Daniel W Fults
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

8.  Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain.

Authors:  Abner Louissaint; Sudha Rao; Caroline Leventhal; Steven A Goldman
Journal:  Neuron       Date:  2002-06-13       Impact factor: 17.173

9.  Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma.

Authors:  John K Wiencke; Shichun Zheng; Nanette Jelluma; Tarik Tihan; Scott Vandenberg; Tanja Tamgüney; Rachel Baumber; Ramon Parsons; Kathleen R Lamborn; Mitchel S Berger; Margaret R Wrensch; Daphne Adele Haas-Kogan; David Stokoe
Journal:  Neuro Oncol       Date:  2007-05-15       Impact factor: 12.300

10.  Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model.

Authors:  Göran Hesselager; Lene Uhrbom; Bengt Westermark; Monica Nistér
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

View more
  6 in total

Review 1.  Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.

Authors:  C von Neubeck; A Seidlitz; H H Kitzler; B Beuthien-Baumann; M Krause
Journal:  Br J Radiol       Date:  2015-07-10       Impact factor: 3.039

2.  Expression of the pituitary stem/progenitor marker GFRα2 in human pituitary adenomas and normal pituitary.

Authors:  Nestoras Mathioudakis; Ram Sundaresh; Alexandra Larsen; William Ruff; Jennifer Schiller; Hugo Guerrero-Cázares; Peter Burger; Roberto Salvatori; Alfredo Quiñones-Hinojosa
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

3.  Poly(ethylene glycol)-Poly(beta-amino ester)-Based Nanoparticles for Suicide Gene Therapy Enhance Brain Penetration and Extend Survival in a Preclinical Human Glioblastoma Orthotopic Xenograft Model.

Authors:  Jayoung Kim; Sujan K Mondal; Stephany Y Tzeng; Yuan Rui; Rawan Al-Kharboosh; Kristen K Kozielski; Adip G Bhargav; Cesar A Garcia; Alfredo Quiñones-Hinojosa; Jordan J Green
Journal:  ACS Biomater Sci Eng       Date:  2020-04-17

4.  Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9.

Authors:  Banu Iskender; Kenan Izgi; Halit Karaca; Halit Canatan
Journal:  J Nat Med       Date:  2015-06-09       Impact factor: 2.343

5.  Failure of the PTEN/aPKC/Lgl Axis Primes Formation of Adult Brain Tumours in Drosophila.

Authors:  Simona Paglia; Manuela Sollazzo; Simone Di Giacomo; Dario de Biase; Annalisa Pession; Daniela Grifoni
Journal:  Biomed Res Int       Date:  2017-12-27       Impact factor: 3.411

6.  Metabolic profiling of dividing cells in live rodent brain by proton magnetic resonance spectroscopy (1HMRS) and LCModel analysis.

Authors:  June-Hee Park; Hedok Lee; Rany Makaryus; Mei Yu; S David Smith; Kasim Sayed; Tian Feng; Eric Holland; Annemie Van der Linden; Tom G Bolwig; Grigori Enikolopov; Helene Benveniste
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.